Overview
| Product name | FITC-Labeled Recombinant Human TNFRSF17/BCMA/CD269 Protein |
|---|
| Catalog No. | RP00612FLQ |
|---|
| Description | FITC-Labeled Recombinant Human TNFRSF17/BCMA/CD269 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Met1-Ala54) of Human TNFRSF17/BCMA/CD269 (Accession #Q02223-1) fused with a C-His&Avi tag at the C-terminus. |
|---|
| Purity | > 95% by SDS-PAGE |
|---|
| Endotoxin | < 1 EU/μg of the protein by LAL method |
|---|
| Formulation | Supplied as 0.22 μm filtered solution in PBS (pH 7.4). |
|---|
| Species | Human |
|---|
| Calculated MW | 8.9 kDa |
|---|
Background
B-cell maturation antigen (BCMA or BCM), also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17), is a protein that in humans is encoded by the TNFRSF17 gene.TNFRSF17 is a cell surface receptor of the TNF receptor superfamily which recognizes B-cell activating factor (BAFF).
Product information
| Synonym | CD269; TNFRSF17; BCMA; BCM; TNFRSF13A |
|---|
| Expression Host | HEK293 cells |
|---|
| Tag | C-His&Avi |
|---|
| Swiss-Prot | |
|---|
| Gene ID | |
|---|
Usage guide
| Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
